AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32598234 — intervention group
Group type: EXPERIMENTAL
Intervention: Overload throwing (5-, 6-, and 9-oz balls)
Number of subjects: 16
Study 32598234 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme overload throwing (5-, 16-, and 32-oz balls)
Number of subjects: 16
Study 32598234 — intervention group
Group type: COMPARATOR
Intervention: Underload throwing (regulation 5-oz baseballs and 4- and 2-oz balls)
Number of subjects: 16
Study 35195838 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical vaginal hysterectomy with laparoscopic assistance
Number of subjects: 0
Study 35195838 — intervention group
Group type: EXPERIMENTAL
Intervention: Creation of a vaginal cuff before radical laparoscopic hysterectomy
Number of subjects: 0
Study 34488085 — intervention group
Group type: EXPERIMENTAL
Intervention: GROUPS 4 HEALTH (G4H)
Number of subjects: 174
Study 34488085 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 174
Study 34488085 — intervention group
Group type: COMPARATOR
Intervention: Control group (before lockdown)
Number of subjects: 174
Study 32608131 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Computer‐assisted Client Assessment Survey (iCCAS)
Number of subjects: 50
Study 32608131 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 50
Study 33265083 — intervention group
Group type: EXPERIMENTAL
Intervention: HTPSG (horseshoe taping for patellar superior gliding)
Number of subjects: 28
Study 33265083 — intervention group
Group type: COMPARATOR
Intervention: HTPIG (horseshoe taping for patellar inferior gliding)
Number of subjects: 28
Study 34318970 — intervention group
Group type: EXPERIMENTAL
Intervention: Burnout
Number of subjects: 397
Study 34318970 — intervention group
Group type: EXPERIMENTAL
Intervention: Work system factors
Number of subjects: 397
Study 34318970 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual mediating factors
Number of subjects: 397
Study 34318970 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levels of burnout
Number of subjects: 397
Study 34318970 — intervention group
Group type: EXPERIMENTAL
Intervention: Consequences of burnout
Number of subjects: 397
Study 34265412 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty (FI ≥ 0.25)
Number of subjects: 339
Study 34265412 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular risk factors (CVRF)
Number of subjects: 339
Study 34265412 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty
Number of subjects: 339
Study 34265412 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between frailty and CVRF
Number of subjects: 339
Study 35930018 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (n=44)
Number of subjects: 100
Study 35930018 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (n=48)
Number of subjects: 100
Study 32090492 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy (PEMF) delivered on perineal area 5 minutes twice daily for 28 days
Number of subjects: 27
Study 32090492 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy (PEMF)
Number of subjects: 27
Study 33176660 — intervention group
Group type: COMPARATOR
Intervention: Traditional medications (RAAS blockers)
Number of subjects: 60
Study 33176660 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin added to traditional medications
Number of subjects: 60
Study 36355633 — intervention group
Group type: COMPARATOR
Intervention: E-book and General chatbot (Xiaoai)
Number of subjects: 148
Study 35118763 — intervention group
Group type: EXPERIMENTAL
Intervention: PACT (Physiotherapy informed by Acceptance and Commitment Therapy)
Number of subjects: 72
Study 35118763 — intervention group
Group type: EXPERIMENTAL
Intervention: PACT
Number of subjects: 72
Study 33536506 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS)
Number of subjects: 2123
Study 32433572 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel
Number of subjects: 21
Study 32433572 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-chitosan gel
Number of subjects: 21
Study 32433572 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid gel
Number of subjects: 21
Study 32433572 — intervention group
Group type: COMPARATOR
Intervention: Neutral water-based gel (placebo)
Number of subjects: 21
Study 34348352 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone valerate 0.1% cream (BMV)
Number of subjects: 0
Study 34348352 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone acetate 1% cream (HC)
Number of subjects: 0
Study 34348352 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone aceponate 0.1% cream (MPA)
Number of subjects: 0
Study 34348352 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus 1% cream (PIM)
Number of subjects: 0
Study 34348352 — intervention group
Group type: COMPARATOR
Intervention: Active agent-free base cream (Dermatop® Basiscreme)
Number of subjects: 0
Study 34348352 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 0
Study 33509248 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee arthroscopy with infrapatellar fat pad cell concentrates containing mesenchymal stromal cells
Number of subjects: 60
Study 33509248 — intervention group
Group type: COMPARATOR
Intervention: Regular knee arthroscopic therapy
Number of subjects: 60
Study 35994013 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.05–0.2 µg/kg/min
Number of subjects: 80
Study 35994013 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 35994013 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 80
Study 35994013 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine and Placebo
Number of subjects: 80
Study 33622026 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-active, absolute cardiovascular risk-guided approach
Number of subjects: 189
Study 33622026 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 189
Study 32715744 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed ultrasound treatment
Number of subjects: 96
Study 32715744 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound treatment
Number of subjects: 96
Study 32715744 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Pulsed ultrasound and Sham ultrasound)
Number of subjects: 96
Study 35968570 — intervention group
Group type: EXPERIMENTAL
Intervention: IM20 × 3
Number of subjects: 215
Study 35968570 — intervention group
Group type: EXPERIMENTAL
Intervention: IM20 × 4
Number of subjects: 215
Study 35968570 — intervention group
Group type: EXPERIMENTAL
Intervention: IM60 × 4
Number of subjects: 215
Study 34323922 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation and metformin
Number of subjects: 167
Study 34323922 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiation alone (Control)
Number of subjects: 167
Study 35650577 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Operating Procedure (SOP)
Number of subjects: 71
Study 35650577 — intervention group
Group type: EXPERIMENTAL
Intervention: Second Workshop (SW)
Number of subjects: 71
Study 35650577 — intervention group
Group type: COMPARATOR
Intervention: Control group (no further intervention)
Number of subjects: 71
Study 32522171 — intervention group
Group type: EXPERIMENTAL
Intervention: PCNL
Number of subjects: 132
Study 32522171 — intervention group
Group type: EXPERIMENTAL
Intervention: MiniPerc (MP)
Number of subjects: 132
Study 32522171 — intervention group
Group type: COMPARATOR
Intervention: Ultraminiperc (UMP)
Number of subjects: 132
Study 35575085 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced e‐cigarette coaching (EEC)
Number of subjects: 96
Study 35575085 — intervention group
Group type: COMPARATOR
Intervention: Quitline treatment as usual (TAU)
Number of subjects: 96
Study 34561340 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 137
Study 34561340 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 137
Study 33271092 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of adjuvant chemotherapy (CAPOX or FOLFOX)
Number of subjects: 12835
Study 33271092 — intervention group
Group type: COMPARATOR
Intervention: 6 months of adjuvant chemotherapy (CAPOX or FOLFOX)
Number of subjects: 12835
Study 33271092 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPOX (3 months)
Number of subjects: 12835
Study 33271092 — intervention group
Group type: COMPARATOR
Intervention: CAPOX (6 months)
Number of subjects: 12835
Study 33271092 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX (3 months)
Number of subjects: 12835
Study 33271092 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX (6 months)
Number of subjects: 12835
Study 33271092 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (3 months vs 6 months)
Number of subjects: 12835
Study 33271092 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (CAPOX)
Number of subjects: 12835
Study 33271092 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (FOLFOX)
Number of subjects: 12835
Study 33271092 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-free survival
Number of subjects: 12835
Study 35283258 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized music intervention (Music Care© application)
Number of subjects: 24
Study 35283258 — intervention group
Group type: COMPARATOR
Intervention: Audiobook control condition
Number of subjects: 24
Study 34039331 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted eccentric calf muscle exercises three times per week alongside regular training.
Number of subjects: 47
Study 34039331 — intervention group
Group type: COMPARATOR
Intervention: Regular training only (Control group).
Number of subjects: 47
Study 34039331 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of both groups.
Number of subjects: 47
Study 33568389 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab intravenous treatment (HDA1)
Number of subjects: 1629
Study 33568389 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab intravenous treatment (HDA2)
Number of subjects: 1629
Study 33568389 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab subcutaneous treatment (HDA1)
Number of subjects: 1629
Study 33568389 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab subcutaneous treatment (HDA2)
Number of subjects: 1629
Study 33568389 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 1629
Study 32376477 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative resistance training (RT), twice a week for 10 weeks prior to THA
Number of subjects: 80
Study 32376477 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (CG)
Number of subjects: 80
Study 36294155 — intervention group
Group type: EXPERIMENTAL
Intervention: Krill oil (3 g/daily)
Number of subjects: 26
Study 36294155 — intervention group
Group type: COMPARATOR
Intervention: Mineral oil (3 g/daily)
Number of subjects: 26
Study 34674300 — intervention group
Group type: EXPERIMENTAL
Intervention: Early functional mobilization (EFM), immediate weightbearing and ankle motion for 6 weeks
Number of subjects: 47
Study 34674300 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (ST), 2 weeks of unloading in a plaster cast followed by 4 weeks of weightbearing in an orthosis
Number of subjects: 47
Study 32570775 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoid-rich orange juice (FR), 380 mL daily, 600 ± 5.4 mg flavonoids
Number of subjects: 40
Study 32570775 — intervention group
Group type: COMPARATOR
Intervention: Flavonoid-low orange cordial (FL), 380 mL daily, 108 ± 2.6 mg flavonoids
Number of subjects: 40
Study 36386033 — intervention group
Group type: EXPERIMENTAL
Intervention: PIA intervention (PC‐supported case management with PIA‐ICT and eLearning)
Number of subjects: 848
Study 36386033 — intervention group
Group type: EXPERIMENTAL
Intervention: PIA intervention
Number of subjects: 848
Study 36386033 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 848
Study 33157378 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposed to bushfires
Number of subjects: 589
Study 33157378 — intervention group
Group type: COMPARATOR
Intervention: Control (not exposed to bushfires)
Number of subjects: 589
Study 33303444 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed perfusion (GDP) strategy during cardiopulmonary bypass (CPB) aimed to maintain DO2i at ≥360 mL/min/m2
Number of subjects: 166
Study 33303444 — intervention group
Group type: COMPARATOR
Intervention: Control group with perfusion strategy based on body surface area and temperature
Number of subjects: 166
Study 33303444 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed perfusion (GDP) strategy
Number of subjects: 166
Study 35797431 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex Active Lifestyle Intervention (CALSTI) consisting of 12 weeks progressive explosive resistance training (24 sessions) enhanced by a 24-week multi-factorial self-management programme (8 sessions)
Number of subjects: 215
Study 35797431 — intervention group
Group type: COMPARATOR
Intervention: Extended version of the self-management intervention (SEMAI; 12 sessions)
Number of subjects: 215
Study 32732515 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (Sal/Val) treatment
Number of subjects: 137
Study 32732515 — intervention group
Group type: COMPARATOR
Intervention: Enalapril treatment (Control)
Number of subjects: 137
Study 32609733 — intervention group
Group type: EXPERIMENTAL
Intervention: Anogenital psoriasis
Number of subjects: 1905
Study 32609733 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-anogenital psoriasis)
Number of subjects: 1905
Study 35380645 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) glucocorticoid injection (triamcinolone acetonide, 40 mg)
Number of subjects: 145
Study 35380645 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular (IA) glucocorticoid injection (triamcinolone acetonide, 40 mg)
Number of subjects: 145
Study 33122571 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine with total intravenous anaesthesia (DEX‐TIVA)
Number of subjects: 177
Study 33122571 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anaesthesia (TIVA)
Number of subjects: 177
Study 32446752 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet + incentives
Number of subjects: 418
Study 32446752 — intervention group
Group type: COMPARATOR
Intervention: Internet-only
Number of subjects: 418
Study 34052706 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D radiomic model
Number of subjects: 74
Study 34052706 — intervention group
Group type: COMPARATOR
Intervention: 2D radiomic model
Number of subjects: 74
Study 33004857 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day AMX+MET
Number of subjects: 75
Study 33004857 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day AMX+MET
Number of subjects: 75
Study 33004857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 34273550 — intervention group
Group type: EXPERIMENTAL
Intervention: Median filter (window 5×5)
Number of subjects: 151
Study 34273550 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid median filter
Number of subjects: 151
Study 34273550 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved adaptive complex diffusion filter (IACDF)
Number of subjects: 151
Study 34273550 — intervention group
Group type: COMPARATOR
Intervention: No filter
Number of subjects: 151
Study 32886243 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted, catheter directed thrombolysis (U-ACDT) using the EkoSonic Endovascular System
Number of subjects: 3
Study 32886243 — intervention group
Group type: COMPARATOR
Intervention: Standard anticoagulation
Number of subjects: 3
Study 32465270 — intervention group
Group type: EXPERIMENTAL
Intervention: <500 mg MMF/day
Number of subjects: 240
Study 32465270 — intervention group
Group type: EXPERIMENTAL
Intervention: >2000 mg MMF/day
Number of subjects: 240
Study 32465270 — intervention group
Group type: COMPARATOR
Intervention: All MMF dosing groups
Number of subjects: 240
Study 35776252 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV stigma reduction intervention
Number of subjects: 1540
Study 33890819 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS-MPH
Number of subjects: 157
Study 33890819 — intervention group
Group type: COMPARATOR
Intervention: atomoxetine
Number of subjects: 157
Study 32462307 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for anxiety in children with ADHD
Number of subjects: 219
Study 35684639 — intervention group
Group type: EXPERIMENTAL
Intervention: Workswell WIRIS Agro R infrared camera (WWARIC)
Number of subjects: 4
Study 33744673 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing the maximum preweaned age within the first housing group
Number of subjects: 1014
Study 33744673 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing mean environmental temperature within the first month of life
Number of subjects: 1014
Study 33744673 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing mean volume of milk feeding
Number of subjects: 1014
Study 33744673 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing the number of days between the cleaning out of calving pen
Number of subjects: 1014
Study 33744673 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing the number of days between the cleaning out of group housing pens
Number of subjects: 1014
Study 34352138 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuranolone 30 mg
Number of subjects: 127
Study 34352138 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuranolone 45 mg
Number of subjects: 127
Study 34352138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 33909356 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with wheat-grain moxibustion
Number of subjects: 60
Study 33909356 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine hydrochloride capsule (20 mg once a day)
Number of subjects: 60
Study 35708946 — intervention group
Group type: EXPERIMENTAL
Intervention: Close targets
Number of subjects: 266
Study 35708946 — intervention group
Group type: COMPARATOR
Intervention: Distant targets
Number of subjects: 266
Study 33245028 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear appeal communication with high response efficacy
Number of subjects: 0
Study 33245028 — intervention group
Group type: COMPARATOR
Intervention: Fear appeal communication with low response efficacy
Number of subjects: 0
Study 33245028 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear and anxiety from threat information exposure
Number of subjects: 0
Study 33245028 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater positivity of cognitive responses
Number of subjects: 0
Study 36476479 — intervention group
Group type: EXPERIMENTAL
Intervention: csDMARDs plus denosumab (60-mg subcutaneous injection once every 6 months for 12 months)
Number of subjects: 43
Study 36476479 — intervention group
Group type: COMPARATOR
Intervention: csDMARD therapy alone
Number of subjects: 43
Study 36476479 — intervention group
Group type: EXPERIMENTAL
Intervention: csDMARDs plus denosumab
Number of subjects: 43
Study 33289818 — intervention group
Group type: EXPERIMENTAL
Intervention: early high‐dose recombinant human erythropoietin (rhEpo)
Number of subjects: 0
Study 33289818 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 34812251 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine added to lidocaine 2%
Number of subjects: 21
Study 34812251 — intervention group
Group type: COMPARATOR
Intervention: Control group (lidocaine 2% only)
Number of subjects: 21
Study 32145017 — intervention group
Group type: EXPERIMENTAL
Intervention: HLPpred-Fuse prediction framework
Number of subjects: 0
Study 32145017 — intervention group
Group type: COMPARATOR
Intervention: Empirical cross-validation analysis
Number of subjects: 0
Study 32145017 — intervention group
Group type: COMPARATOR
Intervention: Independent test and case study
Number of subjects: 0
Study 35458106 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-FODMAPs Diet (LFD)
Number of subjects: 0
Study 35458106 — intervention group
Group type: EXPERIMENTAL
Intervention: Tritordeum-Based Diet (TBD)
Number of subjects: 0
Study 34280568 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial envelope
Number of subjects: 6800
Study 34280568 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6800
Study 34280568 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 6800
Study 32961542 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg memantine
Number of subjects: 42
Study 32961542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34882890 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Learning models based on sagittal, coronal, and axial MR images
Number of subjects: 304
Study 33882525 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy plus surgery
Number of subjects: 0
Study 33882525 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study 33278026 — intervention group
Group type: EXPERIMENTAL
Intervention: Beliefs-only condition
Number of subjects: 384
Study 33278026 — intervention group
Group type: EXPERIMENTAL
Intervention: Approaches-only condition
Number of subjects: 384
Study 33278026 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined beliefs and approaches condition
Number of subjects: 384
Study 33278026 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 384
Study 32276674 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality glasses
Number of subjects: 9
Study 35869707 — intervention group
Group type: EXPERIMENTAL
Intervention: Gegen Qinlian Decoction combined with a Chinese herbal hot package
Number of subjects: 100
Study 35869707 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medical treatment
Number of subjects: 100
Study 32777456 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative chemotherapy educational tool with optional life expectancy information
Number of subjects: 186
Study 32777456 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 186
Study 32646453 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented TKA
Number of subjects: 110
Study 32646453 — intervention group
Group type: COMPARATOR
Intervention: Uncemented TKA
Number of subjects: 110